Affiliation:
1. V. Serbsky National Medical Research Centre for Psychiatry and Narcology
Abstract
Quantitative determination of the brain-derived neurotrophic factor can serve as an important factor in the detection of latent depressions and a marker of the effectiveness of the selected therapy. As a result of immunization with recombinant brain-derived neurotrophic factor, mono- and polyclonal antibodies were obtained. The test system for quantitative enzyme immunoassay on the basis of these components has been developed. It can be used to determine serum levels of this antigen in depressive patients.
Publisher
CO LTD "EXPO-BIOHIM-TEXNOLOGIES"